The significance of the ecosystem value and its effect on the fish distribution in Sibau sub-watershed von Putra, RAE, Aripin, Andono, A, Mahmud, A

Volltext

Portrait of the Artist as a Schoolboy: Bao Tianxiao's Creative Interventions in "Little Xin's School Journal" von Sibau, Maria Franca

Volltext

A randomised phase II study of docetaxel/oxaliplatin and docetaxel in patients with previously treated non-small cell lung cancer: An Alpe–Adria Thoracic Oncology Multidisciplinary... von Belvedere, Ornella, Follador, Alessandro, Rossetto, Ciro, Merlo, Valentina, Defferrari, Carlotta, Sibau, Angela M, Aita, Marianna, Dal Bello, Maria G, Meduri, Stefano, Gaiardo, Marica, Fasola, Gianpiero, Grossi, Francesco

Volltext

Cisplatin and gemcitabine in non-small-cell lung cancer von CARTEI, G, SACCO, C, SIBAU, A, PELLA, N, IOP, A, TABARO, G

Volltext

Final report of a randomized phase II study of docetaxel/oxaliplatin (DO) and docetaxel (D) in previously treated non-small cell lung cancer (NSCLC) patients (pts). A novel design,... von Belvedere, O., Follador, A., Rossetto, C., Sibau, A. M., Defferrari, C., Aita, M., Meduri, S., Fasola, G., Ceschia, T., Grossi, F.

Volltext

Filiality, Cannibalism, Sanctity: Fleshing Out Gegu in a Late Ming Tale of a Filial Girl von SIBAU, Maria Franca

Volltext

P-764 Phase II study of topotecan plus gemcitabine in previously treated small cell lung cancer (SCLC) patients: An Alpe-Adria Thoracic Oncology Multidisciplinary Group study (ATOM... von Grossi, F., Ardizzori, A., Sacco, C., Rossetto, C., Sibau, A., Tumolo, S., Rizzato, S., Piga, A., Fasola, G., Belvedere, O.

Volltext

Afatinib vs erlotinib as second-line therapy of patients with advanced SCC of the lung following platinum-based chemotherapy: OS analysis from the global phase III trial LUX-Lung 8... von Morabito, A., Brandes, A.A., Sibau, A., Ciuffreda, L., Favaretto, A., Cappuzzo, F., Santoro, A., Vasile, E., Brighenti, M., Ferraù, F., Giordano, P., Tiseo, M., Soria, J., Felip, E., Lu, S., Goss, G.D., Gadgeel, S., Georgoulias, V., Chand, V.K., Ardizzoni, A.

Volltext

A phase II study of induction chemotherapy with gemcitabine (G) and cisplatin (P) in locally advanced non-small cell lung cancer: interim analysis von Santo, Antonio, Pedersini, R, Pasini, F, Terzi, A, Pari, F, Cartei, G, Sibau, A, Molino, A, Maiorino, A, Panza, N, Oletti, M.V, Maluta, S, Calabrò, F, Cetto, G.L

Volltext

Mitomycin C, cisplatin, and 5-fluorouracil for advanced and/or recurrent head and neck squamous cell carcinomas von IOP, A, CARTEI, G, VIGEVANI, E, CLOCCHIATTI, L, MANSUTTI, M, SIBAU, A. M

Volltext

Integrated care pathways (ICPs) for non-small cell lung cancer (NSCLC) patients (Pts): A multidisciplinary quality improvement project von Rizzato, S., Merlo, V., Aita, M., Sibau, A., Menis, J., Gurrieri, L., Lugatti, E., Gaiardo, M., Meduri, S., Giacomuzzi, F., Tozzi, V., Fasola, G.

Volltext

Final results of a phase II study of Gemcitabine (G) and Platin (P) in advanced non-small cell lung cancer (NSCLC): Long-term follow up and intention-to-treat analysis von Sacco, C., Cartei, G., Sibau, A., Bearz, A., Gusella, M., Iop, A., Vigevani, E., De Pangher, V.M., Lucenti, A., Tabaro, G., Talamini, R.

Volltext

Cisplatin and gemcitabine in non-small-cell lung cancer von Cartei, G., Sacco, C., Sibau, A., Pella, N., Iop, A., Tabaro, G.

Volltext

Cyclophosphamide, epirubicin, and vincristine (CEV) vs cisplatin and etoposide (PE) in the treatment of small cell lung cancer (SCLC): A randomized study: Trovò MG, Minatel E, Nascimben O, Veronesi A, Foladore S, Della Valentina M, Cartei G, Magri MD, Crivellari D, Franchin G, Boccieri MG, Sibau A, Conte G, Monfardini S. North-Eastern Italian Oncology Group (GOCCNE) - Operation Office C.R.O. Aviano (PN) - Italy

Volltext

Cisplatin and etoposide versus cyclophosphamide, epirubicin and vincristine in small cell lung cancer: a randomised study von Veronesi, A, Cartei, G, Crivellari, D, Magri, M D, Della Valentina, M, Foladore, S, Trovò, M G, Nascimben, O, Sibau, A, Talamini, R

Volltext

Second line chemotherapy with topotecan and gemcitabine in small cell lung cancer (SCLC) patients: An Alpe-Adria Thoracic Oncology Multidisciplinary group phase II study (ATOM 012) von Belvedere, O., Sacco, C., Ardizzoni, A., Rossetto, C., Follador, A., Sibau, A., Tumolo, S., Defferrari, C., Fasola, G., Grossi, F.

Volltext

Tumor measurements on computed tomographic images of non–small cell lung cancer were similar among cancer professionals from different specialties von Grossi, Francesco, Belvedere, Ornella, Fasola, Gianpiero, Ceschia, Tino, Meduri, Stefano, Sibau, Angela, Sacco, Cosimo, Bazzocchi, Massimo, Talmassons, Giovanni, Morelli, Angelo, Barbone, Fabio, Sobrero, Alberto

Volltext

Phase II study of irinotecan and docetaxel in patients with previously treated non-small cell lung cancer: An Alpe-Adria Thoracic Oncology Multidisciplinary group study (ATOM 007) von Grossi, Francesco, Fasola, Gianpiero, Rossetto, Ciro, Spizzo, Riccardo, Meduri, Stefano, Sibau, Angela, Vigevani, Enrico, Tumolo, Salvatore, Adami, Gianna, Sacco, Cosimo, Recchia, Leonardo, Rizzato, Simona, Ceschia, Tino, Belvedere, Ornella

Volltext

Irinotecan plus docetaxel in previously treated non-small cell lung cancer (NSCLC): An Alpe Adria Thoracic Oncology Multidisciplinary group phase II study (ATOM 007) von Grossi, F., Belvedere, O., Rossetto, C., Sibau, A., Vigevani, E., Recchia, L., Sacco, C., Iop, A., Tumolo, S., Fasola, G.

Volltext

Irinotecan plus docetaxel in previously treated non-small cell lung cancer (NSCLC): An Alpe Adria Thoracic Oncology Multidisciplinary group phase II study (ATOM 007) von Grossi, F., Belvedere, O., Rossetto, C., Sibau, A., Vigevani, E., Recchia, L., Sacco, C., Iop, A., Tumolo, S., Fasola, G.

Volltext